Frank Sorgi | President and Chief Executive Officer
FLAG Therapeutics

Frank Sorgi, President and Chief Executive Officer,
FLAG Therapeutics

Frank Sorgi is President & CEO of FLAG Therapeutics, Inc.  FLAG is developing small molecule therapeutics to treat rare cancers.  FLAG's leading clinical asset is FLAG-003, entering the clinic to treat DIPG (Diffuse Intrinsic Pontine Glioma), a rare and fatal pediatric brain tumor, and...